Zhejiang Medicine Co Ltd (600216) — Financial Flexibility Index
Zhejiang Medicine Co Ltd (600216) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥770.79 Million (operating CF CN¥690.77 Million minus capex CN¥80.03 Million) represents 0% of total liabilities (CN¥2.92 Billion). Check 600216 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Medicine Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Zhejiang Medicine Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see Zhejiang Medicine Co Ltd cash flow conversion.
Annual Financial Flexibility Index for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Medicine Co Ltd. Explore Zhejiang Medicine Co Ltd (600216) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥2.33 Billion | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +18.9% |
| 2024 | 0.65x | CN¥1.91 Billion | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +27.5% |
| 2023 | 0.51x | CN¥1.43 Billion | CN¥634.31 Million | CN¥2.79 Billion | ▼ -6.8% |
| 2022 | 0.55x | CN¥1.50 Billion | CN¥520.60 Million | CN¥2.72 Billion | ▼ -11.3% |
| 2021 | 0.62x | CN¥2.08 Billion | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -14.6% |
| 2020 | 0.73x | CN¥1.79 Billion | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +49.9% |
| 2019 | 0.48x | CN¥1.02 Billion | CN¥447.25 Million | CN¥2.11 Billion | ▼ -6.8% |
| 2018 | 0.52x | CN¥1.02 Billion | CN¥579.91 Million | CN¥1.96 Billion | ▼ -2.6% |
| 2017 | 0.53x | CN¥1.07 Billion | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.3% |
| 2016 | 0.39x | CN¥717.90 Million | CN¥336.14 Million | CN¥1.82 Billion | ▼ -22.6% |
| 2015 | 0.51x | CN¥831.50 Million | CN¥106.54 Million | CN¥1.63 Billion | ▼ -56.8% |
| 2014 | 1.18x | CN¥1.54 Billion | CN¥549.90 Million | CN¥1.31 Billion | ▼ -31.2% |
| 2013 | 1.71x | CN¥1.84 Billion | CN¥655.09 Million | CN¥1.08 Billion | ▼ -15.9% |
| 2012 | 2.04x | CN¥1.75 Billion | CN¥807.49 Million | CN¥860.73 Million | ▲ +29.4% |
| 2011 | 1.57x | CN¥1.26 Billion | CN¥912.75 Million | CN¥798.63 Million | ▼ -16.7% |
| 2010 | 1.89x | CN¥1.46 Billion | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.9% |
| 2009 | 1.59x | CN¥1.62 Billion | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +73.4% |
| 2008 | 0.92x | CN¥1.33 Billion | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +373.9% |
| 2007 | 0.19x | CN¥381.05 Million | CN¥227.67 Million | CN¥1.97 Billion | ▼ -19.3% |
| 2006 | 0.24x | CN¥419.49 Million | CN¥169.51 Million | CN¥1.75 Billion | ▼ -3.7% |
| 2005 | 0.25x | CN¥367.08 Million | CN¥25.14 Million | CN¥1.48 Billion | ▲ +17.6% |
| 2004 | 0.21x | CN¥252.40 Million | CN¥107.60 Million | CN¥1.19 Billion | ▲ +11.4% |
| 2003 | 0.19x | CN¥197.57 Million | CN¥66.20 Million | CN¥1.04 Billion | ▼ -19.3% |
| 2002 | 0.24x | CN¥236.94 Million | CN¥23.13 Million | CN¥1.01 Billion | ▲ +2.9% |
| 2001 | 0.23x | CN¥218.69 Million | CN¥98.25 Million | CN¥956.66 Million | ▲ +36.5% |
| 2000 | 0.17x | CN¥134.28 Million | CN¥10.58 Million | CN¥801.61 Million | ▲ +419.4% |
| 1999 | 0.03x | CN¥35.32 Million | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -86.3% |
| 1998 | 0.23x | CN¥183.80 Million | CN¥57.72 Million | CN¥782.87 Million | — |